Södersjukhuset, även kallat och förkortat Sös, är ett akutsjukhus beläget på Södermalm i centrala Stockholm. Byggnaden uppfördes och utrustades under andra världskriget. För utförandet stod arkitekterna Hjalmar Cederström och Hermann Imhäuser med Toll Byggnads AB som entreprenör.

During the past decade, Södersjukhuset conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 15 clinical trials were completed, i.e. on average, 18.3% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 8 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Södersjukhuset" #1 sponsor was "Karolinska Institutet" with 32 trials, followed by "Karolinska University Hospital" with 7 trials sponsored, "Uppsala University" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Södersjukhuset" #1 collaborator was "Stockholm South General Hospital" with 15 trials as a collaborator, "The Swedish Research Council" with 6 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 4 trials as a collaborator, "Danderyd Hospital" with 4 trials as a collaborator and "Karolinska Institutet" with 4 trials as a collaborator. Other collaborators include 129 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Södersjukhuset" are "Coronary Artery Disease" (8 trials), "Myocardial Infarction" (6 trials), "Stroke" (5 trials), "Atrial Fibrillation" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Södersjukhuset" in a lesser frequency.

Most popular intervention types in "Södersjukhuset" are "Drug" (47 trials), "Other" (22 trials), "Device" (19 trials), "Procedure" (18 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Apixaban" (3 trials), "Apixaban matching placebo" (2 trials), "Dexamethasone" (2 trials) and "Exercise" (2 trials). Other intervention names were less common.

The vast majority of trials in "Södersjukhuset" are 91 trials for "All" genders, 20 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Södersjukhuset". undefined are not yet recruiting, 23 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 65 completed trials in Södersjukhuset, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Södersjukhuset, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 45 trials that are defined as “Not Applicable".

Södersjukhuset has several departments that took part in Clinical trials: "Sodersjukhuset; Onkologkliniken" - 5 trials, "Urology Clinic, Sodersjukhuset AB" - 2 trials